Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe® System, showing promise for improving the ...
VANCOUVER, British Columbia — Kardium Inc., a private medical device company that has developed the Globe® System for the treatment of atrial fibrillation (AF), announced positive results of the 1-year outcomes of the First-in-Human PULSE-EU Trial. These …